Bunge director receives 1,654 RSU equity award

Lustosa de Andrade Eliane Aleixo reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Lustosa de Andrade Eliane Aleixo reported acquisition or exercise transactions in this Form 4 filing.

Bunge Global SA director Eliane Aleixo Lustosa de Andrade received an equity award in the form of restricted stock units. The award covers 1,654 RSUs, each convertible into one share of Bunge common stock at no purchase price. These RSUs are expected to vest in full on May 20, 2027, subject to the award terms. Following this grant, Lustosa de Andrade holds 7,273 shares of Bunge common stock in total. This transaction reflects a compensation-related share award rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 1,654 shares

Grant/Award 1 txn

Insider Lustosa de Andrade Eliane Aleixo

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,654	$0.00	$0.00

Holdings After Transaction: Common Stock — 7,273 shares (Direct)

Footnotes (1)

1. F1. Represents an award of Restricted Stock Units ("RSUs"). One RSU is convertible into one share of Bunge common stock. RSUs are expected to vest in full on May 20, 2027.

Key Figures

RSUs granted: 1,654 units Price per share: $0.00 per share Total shares after grant: 7,273 shares +1 more

4 metrics

RSUs granted 1,654 units Restricted stock unit award to director on May 20, 2026

Price per share $0.00 per share Grant price for awarded RSUs

Total shares after grant 7,273 shares Director’s holdings following RSU award

Vesting date May 20, 2027 RSUs expected to vest in full on this date

Key Terms

Restricted Stock Units, RSUs, Form 4, Grant, award, or other acquisition, +1 more

5 terms

Restricted Stock Units financial

"Represents an award of Restricted Stock Units ("RSUs")."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSUs financial

"One RSU is convertible into one share of Bunge common stock."

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Bunge Global SA (BG) report for Eliane Aleixo Lustosa de Andrade?

Bunge Global SA reported a grant of 1,654 restricted stock units to director Eliane Aleixo Lustosa de Andrade. Each RSU converts into one common share, reflecting equity-based compensation rather than an open-market stock purchase.

How many Bunge (BG) shares does Eliane Aleixo Lustosa de Andrade hold after this Form 4 transaction?

After the reported grant, Eliane Aleixo Lustosa de Andrade holds 7,273 shares of Bunge common stock. This total includes the newly awarded 1,654 restricted stock units, which convert into common shares according to the award terms.

When do the newly granted Bunge (BG) restricted stock units vest for Eliane Aleixo Lustosa de Andrade?

The 1,654 restricted stock units granted to Eliane Aleixo Lustosa de Andrade are expected to vest in full on May 20, 2027. Vesting must occur before the RSUs convert into Bunge common stock for the director.

Was cash paid for the Bunge (BG) shares reported in this Form 4 filing?

No cash was paid for these shares; the Form 4 shows a price per share of $0.00. The award represents equity compensation in the form of restricted stock units rather than a cash-funded market purchase.

Is the Bunge (BG) Form 4 transaction a buy or a compensation grant?

The Form 4 reflects a compensation-related grant, not a market buy. Eliane Aleixo Lustosa de Andrade received 1,654 restricted stock units as an award, classified as a grant or other acquisition under SEC transaction code A.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/22/2026 - 04:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lustosa de Andrade Eliane Aleixo

(Last) (First) (Middle)

C/O BUNGE GLOBAL SA

1391 TIMBERLAKE MANOR PARKWAY

(Street)

CHESTERFIELD MISSOURI 63017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bunge Global SA [ BG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/20/2026		A		1,654(1)	A	$0	7,273	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of Restricted Stock Units ("RSUs"). One RSU is convertible into one share of Bunge common stock. RSUs are expected to vest in full on May 20, 2027.

Remarks:

	/s/ Drew Yaeger, Attorney-in-Fact	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)